PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Novumed, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novumed Life Science Consulting and Advisory - Publication Series NOVUMED® SPOTLIGHT - East German doctors prescribe significantly more high-priced biopharmaceutical medication than West German doctors - Novumed.com
Novumed Life Science Consulting and Advisory - Publication Series NOVUMED® SPOTLIGHT

 

NewswireToday - /newswire/ - Tampa, FL, United States, 2014/02/13 - East German doctors prescribe significantly more high-priced biopharmaceutical medication than West German doctors - Novumed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

127 % higher revenues of pharmaceutical companies per physician and year in Eastern Germany. Doctors in the east with traditionally lower price sensitivity. Differentiation of different products is hardly used.

Over 20 years after the reunification there are big differences in the prescription habits of high priced biopharmaceutical medication (biologics) in East and West Germany. Pharmaceutical companies averagely earn more than twice the amount in the east, per physician and year, than in the west with certain biologics. What are the reasons for this and what are implications for pharmaceutical firms and cost drivers?
NOVUMED® analyzed the distribution capabilities in the German pharmaceutical market by using two case studies in cooperation with a leading data provider. The results will be published within the framework of the publication series NOVUMED® SPOTLIGHT.

A success story: inflammation inhibiting biopharmaceuticals
Biopharmaceuticals for the treatment of inflammatory diseases look back upon a perennial success story. For example the medication Humira, from the US-firm Abbott (Abbvie) with global revenues of 9.3 billion $US (2012), is leading the list of Blockbuster medication by far. Currently, 8 significant biopharmaceuticals for the treatment of rheumatoid arthritis (RA) and/or chronic inflammatory bowel disease are licensed in Germany. Together, these drugs show a total revenue of 25.5 billion $US (2012) and an annual growth rate of 12 %.
Due to the high cost of biologics (at CED ca. factor 10 over the standard therapy) the prognoses for market development in the coming years shows significantly lower growth rates.

Eastern Germany is the most attractive sales region for biopharmaceuticals
Especially against this background it is appellative that, in Eastern Germany, certain biologics achieve 127% higher revenues per physician and year than in the west. Doctors in Eastern German prescribe these medications more often and in higher amounts. The NOVUMED® analysis shows that this mainly results from the historically/culturally lower price sensitivity of doctors in Eastern Germany. The questioned physicians also mainly trust the established products on the market and distinguishing features of newer anti-inflammatory biologics are perceived very little.

In an environment of increasing cost pressure on the health system and cumulative challenging framework requirements for the pharmaceutical industry, a detailed understanding of the market is curtail for an efficient distribution.

About Novumed

Novumed Life Science Consulting & Advisory (novumed.com) is an independent Strategy Consulting and Advisory Company for the Life Science Industry. With offices in the US and Europe, NOVUMED® is one of the few consulting firms with clear industrial focus. The experienced team of Management Advisors and Advisory Consultants supports Life Science companies, associated industrial groups and investors with the creation and implementation of market strategies, sales optimization and strategic financial transactions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Novumed, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Novumed Life Science Consulting and Advisory - Publication Series NOVUMED® SPOTLIGHT

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Roland Stief - Novumed.com 
813-223-3442 roland.stief[.]novumed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Novumed, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Novumed, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)